中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
20期
87-88
,共2页
调强放疗%化疗%中晚期鼻咽癌%疗效
調彊放療%化療%中晚期鼻嚥癌%療效
조강방료%화료%중만기비인암%료효
IMRT%Chemotherapy%Advanced nasopharyngeal carcinoma%Efifcacy
目的:探讨应用同步化疗联合后程调强放疗治疗中晚期鼻咽癌的治疗效果。方法选取我院从2013年7月至2014年5月入院治疗的69例鼻咽癌患者做为研究对象。按照入院顺序随机分为观察组34例与对照组35例,对照组患者应用调强放疗技术治疗,观察组患者在对照组患者调强放疗时同步实施化疗。对比两组患者的临床治疗效果及治疗后患者生存状况,不良反应发生情况。结果观察组患者的治疗总有效率显著高于对照组患者,差异具统计学意义(P<0.05)。观察组患者放化疗后5年生存状况显著优于对照组,差异具统计学意义(P<0.05)。结论在中晚期鼻咽癌患者应用调强放疗配合同步化疗临床效果显著,患者生存状况显著改善,治疗不良反应未加重,安全有效,值得广泛推广应用。
目的:探討應用同步化療聯閤後程調彊放療治療中晚期鼻嚥癌的治療效果。方法選取我院從2013年7月至2014年5月入院治療的69例鼻嚥癌患者做為研究對象。按照入院順序隨機分為觀察組34例與對照組35例,對照組患者應用調彊放療技術治療,觀察組患者在對照組患者調彊放療時同步實施化療。對比兩組患者的臨床治療效果及治療後患者生存狀況,不良反應髮生情況。結果觀察組患者的治療總有效率顯著高于對照組患者,差異具統計學意義(P<0.05)。觀察組患者放化療後5年生存狀況顯著優于對照組,差異具統計學意義(P<0.05)。結論在中晚期鼻嚥癌患者應用調彊放療配閤同步化療臨床效果顯著,患者生存狀況顯著改善,治療不良反應未加重,安全有效,值得廣汎推廣應用。
목적:탐토응용동보화료연합후정조강방료치료중만기비인암적치료효과。방법선취아원종2013년7월지2014년5월입원치료적69례비인암환자주위연구대상。안조입원순서수궤분위관찰조34례여대조조35례,대조조환자응용조강방료기술치료,관찰조환자재대조조환자조강방료시동보실시화료。대비량조환자적림상치료효과급치료후환자생존상황,불량반응발생정황。결과관찰조환자적치료총유효솔현저고우대조조환자,차이구통계학의의(P<0.05)。관찰조환자방화료후5년생존상황현저우우대조조,차이구통계학의의(P<0.05)。결론재중만기비인암환자응용조강방료배합동보화료림상효과현저,환자생존상황현저개선,치료불량반응미가중,안전유효,치득엄범추엄응용。
ObjectiveTo investigate the synchronization process after chemotherapy treatment intensity modulation radiotherapy in the treatment of nasopharyngeal carcinoma.MethodOur hospital from July 2013 to May 2014 69 hospitalized patients with NPC as the object of study. According to the order of admission were randomly divided into observation group and control group 34 cases, 35 cases in the control group of patients application intensity modulation radiotherapy treatment, the observation group were implemented simultaneously in the control group of patients with chemotherapy IMRT. Clinical outcomes compared two groups of patients and survival status of patients, the incidence of adverse reactions after treatment.ResultTreatment of patients in the observation group were signiifcantly higher total efifciency of patients, statistically signiifcant differences (P<0.05). Observed in patients after chemotherapy and 5-year survival was signiifcantly better than the control group, the difference statistically signiifcant (P <0.05).ConclusionApplication tune in patients with advanced nasopharyngeal carcinoma radiotherapy with concurrent chemotherapy strongly significant clinical effect, significantly improved survival of patients, the treatment did not increase the side effects, safe and effective, it is widely used.